Function of p21 (Cip1/Waf1/
CDKN1A
ERK3/MAPK6
MMP2
TIMP2
invasion
p21
trophoblastic cell lines
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
15 Jul 2019
15 Jul 2019
Historique:
received:
13
06
2019
revised:
11
07
2019
accepted:
12
07
2019
entrez:
18
7
2019
pubmed:
18
7
2019
medline:
18
7
2019
Statut:
epublish
Résumé
Tumor progression and pregnancy have several features in common. Tumor cells and placental trophoblasts share many signaling pathways involved in migration and invasion. Preeclampsia, associated with impaired differentiation and migration of trophoblastic cells, is an unpredictable and unpreventable disease leading to maternal and perinatal mortality and morbidity. Like in tumor cells, most pathways, in which p21 is involved, are deregulated in trophoblasts of preeclamptic placentas. The aim of the present study was to enlighten p21's role in tumorigenic choriocarcinoma and trophoblastic cell lines. We show that knockdown of p21 induces defects in chromosome movement during mitosis, though hardly affecting proliferation and cell cycle distribution. Moreover, suppression of p21 compromises the migration and invasion capability of various trophoblastic and cancer cell lines mediated by, at least partially, a reduction of the extracellular signal-regulated kinase 3, identified using transcriptome-wide profiling, real-time PCR, and Western blot. Further analyses show that downregulation of p21 is associated with reduced matrix metalloproteinase 2 and tissue inhibitor of metalloproteinases 2. This work evinces that p21 is involved in chromosome movement during mitosis as well as in the motility and invasion capacity of trophoblastic and cancer cell lines.
Identifiants
pubmed: 31311187
pii: cancers11070989
doi: 10.3390/cancers11070989
pmc: PMC6678555
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : project number 390921723
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Références
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
J Biol Chem. 2000 Aug 25;275(34):26411-5
pubmed: 10827175
Am J Pathol. 2000 Oct;157(4):1337-51
pubmed: 11021837
Hum Reprod. 2003 May;18(5):959-68
pubmed: 12721169
Carcinogenesis. 2003 Aug;24(8):1325-36
pubmed: 12807721
J Biol Chem. 2004 Jan 16;279(3):1885-91
pubmed: 14559914
Reprod Biol Endocrinol. 2004 Aug 04;2:59
pubmed: 15294019
Cancer Res. 2005 May 15;65(10):3980-5
pubmed: 15899785
Histochem Cell Biol. 2006 Jun;125(6):615-24
pubmed: 16491347
Cell Cycle. 2006 Jun;5(12):1313-9
pubmed: 16775416
Biochim Biophys Acta. 2007 Aug;1773(8):1376-87
pubmed: 17161475
Cell Cycle. 2006 Dec;5(24):2899-902
pubmed: 17172866
Cell Tissue Res. 2007 Dec;330(3):527-34
pubmed: 17955263
Placenta. 2008 Feb;29(2):175-86
pubmed: 18155142
J Cell Biol. 1991 Apr;113(2):437-49
pubmed: 1849141
Placenta. 2008 Sep;29(9):772-83
pubmed: 18706691
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Cell Cycle. 2009 Feb 1;8(3):460-72
pubmed: 19177004
Nat Rev Cancer. 2009 Jun;9(6):400-14
pubmed: 19440234
Biochem J. 2010 Apr 28;428(1):103-11
pubmed: 20236090
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
Lancet. 2010 Aug 21;376(9741):631-44
pubmed: 20598363
J Biol Chem. 2011 Feb 25;286(8):6470-8
pubmed: 21177870
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Science. 2011 Mar 25;331(6024):1559-64
pubmed: 21436443
Placenta. 2011 Sep;32(9):665-670
pubmed: 21764444
J Clin Invest. 2012 May;122(5):1869-80
pubmed: 22505454
Oncogene. 2013 May 2;32(18):2292-2303.e7
pubmed: 22751124
J Mol Signal. 2012 Jul 16;7(1):9
pubmed: 22800433
Oncotarget. 2012 Aug;3(8):759-73
pubmed: 22929622
Breast Cancer Res. 2012 Sep 20;14(5):R127
pubmed: 22995475
Mol Hum Reprod. 2013 Apr;19(4):237-49
pubmed: 23220688
Rev Obstet Gynecol. 2012;5(3-4):e137-43
pubmed: 23483768
J Cell Sci. 2013 Oct 1;126(Pt 19):4358-68
pubmed: 23886938
PLoS One. 2013 Sep 19;8(9):e73337
pubmed: 24069188
Oncogene. 2014 Dec 11;33(50):5716-28
pubmed: 24317508
PLoS One. 2014 Jan 30;9(1):e87621
pubmed: 24498154
Oncogene. 2015 Apr 2;34(14):1758-67
pubmed: 24858045
Mol Hum Reprod. 2014 Oct;20(10):1026-40
pubmed: 25024139
Front Physiol. 2014 Oct 10;5:372
pubmed: 25346691
Oncotarget. 2015 Mar 30;6(9):6611-26
pubmed: 25483104
Cell Cycle. 2015;14(23):3755-67
pubmed: 26148251
PLoS One. 2015 Sep 02;10(9):e0136797
pubmed: 26331622
Cell Adh Migr. 2015;9(6):483-94
pubmed: 26588708
Cell Adh Migr. 2016 Mar 3;10(1-2):163-78
pubmed: 26744771
Histochem Cell Biol. 2016 Aug;146(2):191-204
pubmed: 27106773
Nat Cell Biol. 2016 Jul;18(7):777-89
pubmed: 27323328
Oncotarget. 2016 Aug 2;7(31):50215-50228
pubmed: 27384476
Histol Histopathol. 2017 Apr;32(4):339-349
pubmed: 27665761
Oncotarget. 2016 Dec 20;7(51):84271-84285
pubmed: 27713178
Mol Oncol. 2017 Feb;11(2):194-207
pubmed: 28079973
Cancer Res. 2017 Jun 1;77(11):3092-3100
pubmed: 28377455
Sci Rep. 2017 Nov 3;7(1):14979
pubmed: 29101390
Nat Commun. 2017 Dec 12;8(1):2050
pubmed: 29234059
Sci Rep. 2018 Jun 25;8(1):9629
pubmed: 29941993
Cell Rep. 2018 Oct 23;25(4):1027-1039.e6
pubmed: 30355482
Placenta. 1987 Jul-Aug;8(4):339-45
pubmed: 3684965
Exp Cell Res. 1993 Jun;206(2):204-11
pubmed: 7684692
Mol Hum Reprod. 1998 May;4(5):477-81
pubmed: 9665634
Science. 1998 Nov 20;282(5393):1497-501
pubmed: 9822382
Exp Cell Res. 1999 Feb 1;246(2):280-9
pubmed: 9925742